Patents by Inventor Frank F. Molock

Frank F. Molock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for manufacture of a thermochromic contact lens material
    Patent number: 11724472
    Abstract: Disclosed in this specification is a process for manufacturing a thermochromic contact lens. The process includes (1) selecting a photoinitiator that absorbs at a first wavelength and at least one thermochromic dye that displays substantial absorption at the first wavelength when the dye is at a first temperature and exhibits at least an 80% reduction in absorbance at the first wavelength at a second temperature, (2) maintaining the reaction mixture at the second temperature and (3) providing cure light that includes the first wavelength.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: August 15, 2023
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Donnie J. Duis, Nayiby Alvarez-Carrigan, Holly L. Grammer, Ture Kindt-Larsen, Frank F. Molock, Jr., Jaqunda Patton, Kim Sander Pedersen, Eric R. George
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20220268966
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: May 13, 2022
    Publication date: August 25, 2022
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Biomedical devices containing internal wetting agents
    Patent number: 11360241
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: June 14, 2022
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS
    Publication number: 20210379005
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g.
    Type: Application
    Filed: August 20, 2021
    Publication date: December 9, 2021
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Esters for treatment of ocular inflammatory conditions
    Patent number: 11096919
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: August 24, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, Jr., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20210149084
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 20, 2021
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • PROCESS FOR MANUFACTURE OF A THERMOCHROMIC CONTACT LENS MATERIAL
    Publication number: 20210101352
    Abstract: Disclosed in this specification is a process for manufacturing a thermochromic contact lens. The process includes (1) selecting a photoinitiator that absorbs at a first wavelength and at least one thermochromic dye that displays substantial absorption at the first wavelength when the dye is at a first temperature and exhibits at least an 80% reduction in absorbance at the first wavelength at a second temperature, (2) maintaining the reaction mixture at the second temperature and (3) providing cure light that includes the first wavelength.
    Type: Application
    Filed: December 17, 2020
    Publication date: April 8, 2021
    Inventors: Donnie J. Duis, Nayiby Alvarez-Carrigan, Holly L. Grammer, Ture Kindt-Larsen, Frank F. Molock, JR., Jaqunda Patton, Kim Sander Pedersen, Eric R. George
  • Biomedical devices containing internal wetting agents
    Patent number: 10935696
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: March 2, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Process for manufacture of a thermochromic contact lens material
    Patent number: 10894374
    Abstract: Disclosed in this specification is a process for manufacturing a thermochromic contact lens. The process includes (1) selecting a photoinitiator that absorbs at a first wavelength and at least one thermochromic dye that displays substantial absorption at the first wavelength when the dye is at a first temperature and exhibits at least an 80% reduction in absorbance at the first wavelength at a second temperature, (2) maintaining the reaction mixture at the second temperature and (3) providing cure light that includes the first wavelength.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: January 19, 2021
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Donnie J. Duis, Nayiby Alvarez-Carrigan, Holly L. Grammer, Ture Kindt-Larsen, Frank F. Molock, Jr., Jaqunda Patton, Kim Sander Pedersen, Eric R. George
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20200233118
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Esters for Treatment of Ocular Inflammatory Conditions
    Publication number: 20200222357
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g.
    Type: Application
    Filed: March 26, 2020
    Publication date: July 16, 2020
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Biomedical devices containing internal wetting agents
    Patent number: 10641926
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: May 5, 2020
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS
    Publication number: 20190328698
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 31, 2019
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, JR., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • Esters for treatment of ocular inflammatory conditions
    Patent number: 10383839
    Abstract: The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: August 20, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Annabelle Gallois-Bernos, Frank F. Molock, Jr., Carrie L. Davis, Kathrine Osborn Lorenz, James K. Young, Kristy L. Canavan, Fang Lu
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20190187332
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 20, 2019
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Biomedical devices containing internal wetting agents
    Patent number: 10254443
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: April 9, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • PROCESS FOR MANUFACTURE OF A THERMOCHROMIC CONTACT LENS MATERIAL
    Publication number: 20180229457
    Abstract: Disclosed in this specification is a process for manufacturing a thermochromic contact lens. The process includes (1) selecting a photoinitiator that absorbs at a first wavelength and at least one thermochromic dye that displays substantial absorption at the first wavelength when the dye is at a first temperature and exhibits at least an 80% reduction in absorbance at the first wavelength at a second temperature, (2) maintaining the reaction mixture at the second temperature and (3) providing cure light that includes the first wavelength.
    Type: Application
    Filed: April 10, 2018
    Publication date: August 16, 2018
    Inventors: Donnie J. Duis, Nayiby Alvarez-Carrigan, Holly L. Grammer, Ture Kindt-Larsen, Frank F. Molock, JR., Jaqunda Patton, Kim Sander Pedersen, Eric R. George
  • Methods and ophthalmic devices used in the treatment of ocular allergies
    Patent number: 10045975
    Abstract: Ophthalmic devices and methods of treating allergic conjunctivitis are disclosed herein.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 14, 2018
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Ranganath R. Raja, Shivkumar Mahadevan, Azaam Alli, Frank F. Molock, Brian Pall
  • BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS
    Publication number: 20180203161
    Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Inventors: Kevin P. McCabe, Frank F. Molock, JR., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
  • Process for manufacture of a thermochromic contact lens material
    Patent number: 9975301
    Abstract: Disclosed in this specification is a process for manufacturing a thermochromic contact lens. The process includes (1) selecting a photoinitiator that absorbs at a first wavelength and at least one thermochromic dye that displays substantial absorption at the first wavelength when the dye is at a first temperature and exhibits at least an 80% reduction in absorbance at the first wavelength at a second temperature, (2) maintaining the reaction mixture at the second temperature and (3) providing cure light that includes the first wavelength.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: May 22, 2018
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Donnie J. Duis, Nayiby Alvarez-Carrigan, Holly L. Grammer, Ture Kindt-Larsen, Frank F. Molock, Jr., Jaqunda Patton, Kim Sander Pedersen, Eric R. George